Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NS5A-IN-3 (Compound 15) serves as a potent NS5A inhibitor, displaying exceptionally high efficacy against HCV genotype 1b, enhanced activity towards genotype 3a (GT 3a), and substantial metabolic stability. It also demonstrates a superior resistance barrier compared to daclatasvir in genotype 1b [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,670.00 | |
50 mg | 8-10 weeks | $ 2,180.00 | |
100 mg | 8-10 weeks | $ 2,800.00 |
Description | NS5A-IN-3 (Compound 15) serves as a potent NS5A inhibitor, displaying exceptionally high efficacy against HCV genotype 1b, enhanced activity towards genotype 3a (GT 3a), and substantial metabolic stability. It also demonstrates a superior resistance barrier compared to daclatasvir in genotype 1b [1]. |
Molecular Weight | 784.86 |
Formula | C44H44N6O8 |
CAS No. | 2764786-56-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NS5A-IN-3 2764786-56-1 Microbiology/Virology Proteases/Proteasome HCV Protease inhibitor inhibit